[Is there a risk in treatment of hypertension with nifedipine?].
作者信息
Düsing R
机构信息
Rheinische Friedrich-Wilhelms-Universität, Medizinische Universitäts-Poliklinik, Bonn.
出版信息
Internist (Berl). 1996 Sep;37(9):939-41.
PMID:8964691
Abstract
摘要
相似文献
1
[Is there a risk in treatment of hypertension with nifedipine?].硝苯地平治疗高血压有风险吗？
Internist (Berl). 1996 Sep;37(9):939-41.
2
Nifedipine and other calcium channel blockers.硝苯地平及其他钙通道阻滞剂。
Eur Heart J. 1997 Jan;18(1):168. doi: 10.1093/oxfordjournals.eurheartj.a015102.
3
Adverse reactions to short-acting nifedipine in hypertensive crises.
Pediatr Nephrol. 1999 May;13(4):366.
4
The nifedipine scare in hypertension: fact or fiction.硝苯地平在高血压治疗中的恐慌：事实还是虚构？
Indian Heart J. 1996 May-Jun;48(3):227-9.
5
Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.舌下含服硝苯地平治疗恶性高血压后出现QT间期延长及心室颤动。
Arch Intern Med. 1997;157(22):2665-6.
6
Short-acting nifedipine.
Pediatr Nephrol. 1997 Dec;11(6):786-7.
7
[Korinfar in the treatment of patients with arterial hypertension].[科林法用于治疗动脉高血压患者]
Vrach Delo. 1986 Sep(9):26-8.
8
Calcium channel blockers, risk of cancer, and the challenge of assessing medication safety.钙通道阻滞剂、癌症风险以及评估药物安全性的挑战。
Tenn Med. 1997 Sep;90(9):367-9.
9
[Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].[长效硝苯地平对墨西哥人群肝脏代谢的影响]
Gac Med Mex. 2002 Jul-Aug;138(4):381-3.
10
[Long-term treatment with calcium antagonists: advantageous effects and risks].[钙拮抗剂的长期治疗：有益作用和风险]
Ned Tijdschr Geneeskd. 1995 Dec 30;139(52):2715-21.
Zotero 插件